Abstract
Injection ofd-amphetamine into the nucleus accumbens potentiates responding for stimuli paired with a primary reward. A previous study showed that this potentiating effect ofd-amphetamine on responding for conditioned reward (CR) was attenuated by peripherally injectedd-fenfluramine, a 5-hydroxytryptamine (5-HT) releaser and re-uptake inhibitor. The present experiments further examined the effects of manipulating 5-HT function within the nucleus accumbens on responding for CR, and on the potentiation of CR responding following intra-accumbens injection ofd-amphetamine. Water deprived rats were trained to associate a compound stimulus with water delivery during a conditioning phase. During a test phase water was not delivered, but the compound stimulus was delivered according to a random ratio 2 schedule following a response on one of two levers. Rats responded at a higher rate on the lever delivering this CR.d-Amphetamine (10 μg) injected into the nucleus accumbens enhanced responding on the CR lever. Co-injections of 5-HT (5 and 10 μg) into the nucleus accumbens abolished the response-potentiating effect ofd-amphetamine but were without effect on the base-line level of responding for CR. This reduction by 5-HT of the response potentiating effect ofd-amphetamine was prevented by prior treatment with the 5-HT receptor antagonist metergoline (1 mg/kg). Responding for water was not altered by 5-HT and so the effects of 5-HT on responding for CR cannot be due to a change in the motivation to seek the primary reward. Thus, elevating 5-HT activity within the nucleus accumbens antagonises the effects ofd-amphetamine on responding for CR within the nucleus accumbens. These results suggest that 5-HT within the nucleus accumbens may play an important role in mediating incentive motivation by modulating dopaminergic neurotransmission.
Similar content being viewed by others
References
Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6:173–196
Benloucif S, Galloway MP (1991). Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1–8
Benloucif S, Keegan MJ, Galloway MP (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 265:373–377
Bonhomme, N, De Deurwaerdere P, Le Moal M, Spampinato U (1995) Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat. Neuropharmacology 34:269–279
Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994) Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115:516–528
Cador M, Robbins TW, Everitt BJ (1989) Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience 30:77–86
Cador M, Taylor JR, Robbins TW (1991) Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology 104:377–385
Carter CJ, Pycock CJ (1978) Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour. Life Sci 23:953–960
Costall B, Hui SCG, Naylor RJ (1979) The importance of serotonergic mechanisms for the induction of hyperactivity by amphetamine and its antagonism by intra-accumbens (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI). Neuropharmacology, 18:605–609
Davis WM, Smith SG (1987) In: Bozarth MA Methods of assessing the reinforcing properties of abused drugs. Springer, Heidelberg, pp 199–210
Fallon JH, Ciofi P (1992) Distribution of monoamines within the amygdala. In: Aggleton JP (ed) The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. Wiley-Liss, New York, pp 97–114
Fibiger HC, Phillips AG (1986) Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems. In: Mountcastle VB, Bloom FE, Geiger SR (eds) Handbook of physiology: the nervous system (vol. 4). American Physiological Society, Bethesda, Maryland, pp 647–675
Fletcher PJ (1995) Effects ofd-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbensd-amphetamine. Psychopharmacology 118:155–163
Fletcher PJ, Ming ZH, Higgins GA (1993) Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nuclei. Psychopharmacology 113:31–36
Fletcher PJ, Tampakeras M, Yeomans JS (1995) Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation. Pharmacol Biochem Behav 52:65–71
Hoffman DC (1989) The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res Bull 23:373–387
Hokfelt T, Rehfeld JF, Skirboll L, Ivemark B, Goldstein M, Markey K (1980) Evidence for coexistence of dopamine and CCK in mesolimbic neurons. Nature 285:476–478
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157–203
Jackson EA, Kelly PH, Schultz L (1985). Effects of serotonergic activity in nucleus accumbens septi on drug-induced circling. Neuropharmacology 24:721–727
Jacocks III HM, Cox BM (1992) Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium,N-methyl-D-aspartic acid, glutamic acid andd-amphetamine. J Pharmacol Exp Ther 262:356–364
Jones DL, Mogenson GJ, Wu M (1981) Injections of dopaminergic, cholinergic, serotonergic and GABAergic drugs into the nucleus accumbens: effects on locomotor activity in the rat. Neuropharmacology 20:29–37
Kelley AE, Delfs JM (1991) Dopamine and conditioned reinforcement I. Differential effects of amphetamine microinjections into striatal subregions. Psychopharmacology 103:187–196
Loh EA, Roberts DCS (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101:262–266
Lyness WH, Moore KE (1981) Destruction of 5-hydroxytryptaminergic neurons and the dynamics of dopamine in nucleus accumbens septi and other forebrain regions of the rat. Neuropharmacology 20:327–334
Lyness WH, Friedle NM, Moore KE (1980) Increased self-administration ofd-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol Biochem Behav 12:937–941
Papp M, Willner P (1991) 8-OH-DPAT -induced place preference and place aversion: effects of PCPA and dopamine antagonists. Psychopharmacology 103:99–102
Parsons LH, Justice JB Jr (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606:195–199
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney
Phillips GD, Le Noury J. Wolterink G, Donselaar-Wolterink I, Robbins TW, Everitt BJ (1993) Cholecsytokinin-dopamine interactions within the nucleus accumbens in the control over behavior by conditioned reinforcement. Behav Brain Res 55:223–231
Plaznik A, Danysz W, Kostowski W (1985) Some behavioural effects of microinjections of noradrenaline and serotonin into the amygdaloid body of the rat brain. Physiol Behav 34:481–487
Poschel BPH, Ninteman FW (1971) Intracranial reward and the forebrain's serotonergic mechanism: studies employingpara-chlorophenylalanine andpara-chloroamphetamine. Pharmacol Biochem Behav 7:39–46
Pucilowski O, Plaznik A, Kostowski W (1985) Aggressive behavior inhibition by serotonin and quipazine injected into the amygdala in the rat. Behav Neural Biol 43:58–68
Redgrave P (1978) Modulation of intracranial self-stimulation behaviour by local perfusions of dopamine, noradrenaline and serotonin within the caudate nucleus and nucleus accumbens. Brain Res 155:277–295
Taylor JR, Robbins TW (1984) Enhanced behavioural control by conditioned reinforcers following microinjections ofd-amphetamine into the nucleus accumbens. Psychopharmacology 84:405–412
Taylor JR, Robbins TW (1986) 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate responding with reward-related stimuli produced by intra-accumbensd-amphetamine. Psychopharmacology 90:390–397
Schiavi GB, Brunet S, Rizzi CA, Ladinsky H (1994) Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding. Neuropharmacology 33: 543–549
Waeber C, Serben M, Nieoullon A, Bockaert J, Dumuis A (1994). Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33:527–541
Wang RY, Aghajanian GK (1977) Inhibition of neurons in the amygdala by dorsal raphe stimulation: mediation through a direct serotonergic pathway. Brain Res 120:85–102
Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fletcher, P.J. Injection of 5-HT into the nucleus accumbens reduces the effects ofd-amphetamine on responding for conditioned reward. Psychopharmacology 126, 62–69 (1996). https://doi.org/10.1007/BF02246412
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246412